US Patent 7507763 Resistance-repellent retroviral protease inhibitors
Patent 7507763 was granted and assigned to Sequoia Pharmaceuticals on March, 2009 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7507763 Resistance-repellent retroviral protease inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.